title: Long-term immune recovery after CD34+ immunoselected and unselected peripheral blood progenitor cell transplantation: a case-control study.
abstract: OBJECTIVE
  CD34+ stem cell selection induces extensive T-cell depletion as a consequence of ex vivo manipulation. The impact of T-cell depletion on long-term immunologic recovery after autologous CD34+ peripheral blood progenitor cell transplantation (CD34+ PBPCT) is not well characterized. We compared the long term immunologic recovery in two groups of patients submitted to CD34+ PBPCT or unselected autologous peripheral blood progenitor cell transplantation (uPBPCT).
  
  
  METHODS
  Eight patients in both groups were closely matched for diagnosis, age, disease status at transplantation and conditioning regimen and lymphocyte phenotype was prospectively evaluated during long-term post-transplantation follow-up.
  
  
  RESULTS
  At a median of 18 months after transplantation, CD3+ lymphocyte subset remained below the normal range in both groups. CD19+ B lymphocytes subset after CD34+ PBPCT was within the normal range in both groups. CD4+ lymphocytes were depressed while the CD8+ lymphocyte subset was increased in group A and in the normal range in group B. As a result, inversion of CD4/CD8 ratio was documented in both groups. T-activated lymphocytes (CD3DR+) and natural killer (CD16/56+) cells were increased in both groups.
  
  
  CONCLUSIONS
  Long-term immune recovery appears to be unaffected by extensive ex vivo manipulation in this adult population when compared to recovery after unmanipulated PBPCT. CD34+ selection, although causes an extensive depletion of T lymphocytes in the graft does not represent a risk factor for delayed CD4+ recovery late after transplantation. Elevated numbers of NK cells and activated T-cells, which have antineoplastic activity, are maintained late after autologous CD34+ transplantation.
authors.affiliation: Divisione di Ematologia, Istituto Semeiotica Medica, Università Cattolica Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy. emacat@rm.unicatt.it
authors.forename: L
authors.initials: L
authors.lastname: Laurenti
authors.forename: S
authors.initials: S
authors.lastname: Sica
authors.forename: F
authors.initials: F
authors.lastname: Sorà
authors.forename: N
authors.initials: N
authors.lastname: Piccirillo
authors.forename: E
authors.initials: E
authors.lastname: Ortu La Barbera
authors.forename: P
authors.initials: P
authors.lastname: Chiusolo
authors.forename: P
authors.initials: P
authors.lastname: Salutari
authors.forename: C
authors.initials: C
authors.lastname: Rumi
authors.forename: S
authors.initials: S
authors.lastname: Rutella
authors.forename: G
authors.initials: G
authors.lastname: Leone
mesh_terms: D000328:Adult; D018952:Antigens, CD34 / Q000097:blood*; D016516:CD4-CD8 Ratio; D016022:Case-Control Studies; D016238:Cytapheresis; D005260:Female; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D018952:Antigens, CD34